PA
AVGO icon

PharVision Advisers’s Broadcom AVGO Stock Holding History

PharVision Advisers’s Portfolio AVGO Stock Details AVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,932
Closed -$669K – 145
2025
Q4 		$669K Buy
+1,932
New +$691K 0.34% 5
2025
Q1 		– Sell
-2,669
Closed -$619K – 286
2024
Q4 		$619K Buy
+2,669
New +$494K 0.52% 23

Other funds holding AVGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PharVision Advisers's AVGO Position: Q1 2026 in Review

PharVision Advisers sold out of Broadcom (AVGO) in Q1 2026, closing a stake of 1,932 shares — an estimated $669K sold.

PharVision Advisers first reported a position in AVGO in Q4 2024 and held it in 2 quarters. The position peaked at $669K in Q4 2025. 4,662 funds tracked by Wall St. Rank hold AVGO as of Q1 2026.

  • PharVision Advisers reported no remaining Broadcom position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 1,932 Broadcom shares in Q1 2026, an estimated $669K.
  • PharVision Advisers first reported a position in Broadcom in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Broadcom position peaked at $669K in Q4 2025.
  • 4,662 funds tracked by Wall St. Rank held Broadcom as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.